연구성과로 돌아가기

2024 연구성과별 연구자 정보 (733 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Ahn, Kyu Jeung Ahn, KJ 4 Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Coll Med, Dept Endocrinol & Metab, Seoul, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Song, Kee-Ho Song, KH 5 Konkuk Univ, Dept Internal Med, Div Endocrinol & Metab, Med Ctr, Seoul, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Song, Kee-Ho Song, KH 5 Daegu Catholic Univ, Div Endocrinol & Metab, Dept Internal Med, Med Ctr, Daegu, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Lee, In-Kyu Lee, IK 6 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Daegu, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Shon, Ho-Sang Shon, HS 7 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Daegu, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, In Joo Kim, IJ 8 Pusan Natl Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Busan, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Lim, Soo Lim, S 9 Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seongnam, South Korea AAU-8107-2020 Lim, Soo leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Doo-Man Kim, DM 10 Hallym Univ, Kangnam Sacred Heart Hosp, Div Endocrinol Metab, Dept Internal Med,Coll Med, Seoul, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Chung, Choon Hee Chung, CH 11 Yonsei Univ, Wonju Severance Christian Hosp, Dept Internal Med, Div Endocrinol & Metab,Wonju Coll Med, Wonju, South Korea 0000-0003-1144-7206 Chung, Choon leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Lee, Won-Young Lee, WY 12 Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Seoul, South Korea AAA-1843-2021 Lee, Da Young leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Lee, Soon Hee Lee, SH 13 Inje Univ, Dept Internal Med, Div Endocrinol & Metab, Busan Paik Hosp, Busan, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Dong Joon Kim, DJ 14 Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Endocrinol & Metab, Goyang, South Korea C-4288-2013 Kim, Donghee leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Cho, Sung-Rae Cho, SR 15 Changwon Fatima Hosp, Dept Internal Med, Div Endocrinol & Metab, Chang Won, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Jung, Chang Hee Jung, CH 16 Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul, South Korea AAU-7897-2020 Jung, Chang leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Jeon, Hyun Jeong Jeon, HJ 17 Chungbuk Natl Univ, Coll Med, Div Endocrinol & Metab, Dept Internal Med,Chungbuk Natl Univ Hosp, Cheongju, South Korea leemk4132@gmail.com;
페이지 이동: